The principal cause of morbidity and mortality in cystic fibrosis is persistent respiratory colonization with mucoid strains of Pseudomonas aeruginosa. To investigate possible mechanisms of resistance to this organism, we studied serum from 16 older (greater than or equal to 12 years) patients not colonized with mucoid P. aeruginosa, 11 older (greater than or equal to 14 years) colonized patients, 10 younger (less than or equal to 11 years) noncolonized patients, and 20 healthy adults. The samples from the older patients not colonized with mucoid P. aeruginosa contained antibody specific to the mucoid-exopolysaccharide antigen, which could mediate bacterial killing in conjunction with complement and white cells (titers of 4 to 80). These opsonophagocytic killing antibodies were not detected in samples from the 20 normal controls (P less than 0.0001 vs. noncolonized older patients) or 9 of 10 younger (less than or equal to 11 years) noncolonized patients (P = 0.0072 vs. noncolonized older patients). Although the patients with chronic colonization had higher titers of serum opsonophagocytic killing antibody than did the older noncolonized patients (P = 0.0005), these antibodies were not specific to the mucoid-exopolysaccharide antigen. We conclude that there is an association between mucoid-exopolysaccharide-specific opsonophagocytic killing antibody and a lack of detectable P. aeruginosa colonization in a subset of older, relatively healthy patients with cystic fibrosis.
This article has been cited by other articles:
Cripps, A. W., Peek, K., Dunkley, M., Vento, K., Marjason, J. K., McIntyre, M. E., Sizer, P., Croft, D., Sedlak-Weinstein, L.
(2006). Safety and Immunogenicity of an Oral Inactivated Whole-Cell Pseudomonas aeruginosa Vaccine Administered to Healthy Human Subjects. Infect. Immun.
74: 968-974
[Abstract][Full Text]
Hoffmann, N., Rasmussen, T. B., Jensen, P., Stub, C., Hentzer, M., Molin, S., Ciofu, O., Givskov, M., Johansen, H. K., Hoiby, N.
(2005). Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis. Infect. Immun.
73: 2504-2514
[Abstract][Full Text]
Pier, G. B., Boyer, D., Preston, M., Coleman, F. T., Llosa, N., Mueschenborn-Koglin, S., Theilacker, C., Goldenberg, H., Uchin, J., Priebe, G. P., Grout, M., Posner, M., Cavacini, L.
(2004). Human Monoclonal Antibodies to Pseudomonas aeruginosa Alginate That Protect against Infection by Both Mucoid and Nonmucoid Strains. J. Immunol.
173: 5671-5678
[Abstract][Full Text]
Theilacker, C., Coleman, F. T., Mueschenborn, S., Llosa, N., Grout, M., Pier, G. B.
(2003). Construction and Characterization of a Pseudomonas aeruginosa Mucoid Exopolysaccharide-Alginate Conjugate Vaccine. Infect. Immun.
71: 3875-3884
[Abstract][Full Text]
Lyczak, J. B., Cannon, C. L., Pier, G. B.
(2002). Lung Infections Associated with Cystic Fibrosis. Clin. Microbiol. Rev.
15: 194-222
[Abstract][Full Text]
Worgall, S., Kikuchi, T., Singh, R., Martushova, K., Lande, L., Crystal, R. G.
(2001). Protection against Pulmonary Infection with Pseudomonas aeruginosa following Immunization with P. aeruginosa-Pulsed Dendritic Cells. Infect. Immun.
69: 4521-4527
[Abstract][Full Text]
Pier, G. B., Coleman, F., Grout, M., Franklin, M., Ohman, D. E.
(2001). Role of Alginate O Acetylation in Resistance of Mucoid Pseudomonas aeruginosa to Opsonic Phagocytosis. Infect. Immun.
69: 1895-1901
[Abstract][Full Text]
Parad, R. B., Gerard, C. J., Zurakowski, D., Nichols, D. P., Pier, G. B.
(1999). Pulmonary Outcome in Cystic Fibrosis Is Influenced Primarily by Mucoid Pseudomonas aeruginosa Infection and Immune Status and Only Modestly by Genotype. Infect. Immun.
67: 4744-4750
[Abstract][Full Text]
Hatano, K., Pier, G. B.
(1998). Complex Serology and Immune Response of Mice to Variant High-Molecular-Weight O Polysaccharides Isolated from Pseudomonas aeruginosa Serogroup O2 Strains. Infect. Immun.
66: 3719-3726
[Abstract][Full Text]
Yu, H., Hanes, M., Chrisp, C. E., Boucher, J. C., Deretic, V.
(1998). Microbial Pathogenesis in Cystic Fibrosis: Pulmonary Clearance of Mucoid Pseudomonas aeruginosa and Inflammation in a Mouse Model of Repeated Respiratory Challenge. Infect. Immun.
66: 280-288
[Abstract][Full Text]
Pier, G., Small, G., Warren, H.
(1990). Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections. Science
249: 537-540
[Abstract]
Previous
